LILLIAN LEIGH DAVIS: Open Payments
NPI 1306092937 · MINDEN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 14 payments from 6 companies in 2025. Trend: 2023 $510 · 2024 $578 · 2025 $251
Food & beverage: $251
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $112 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Lilly USA, LLC | 2 | $32 |
| Exact Sciences Corporation | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $15 |
Products named: VRAYLAR, AIRSUPRA, JARDIANCE, UBRELVY, The Cologuard Plus Collection Kit, BREZTRI, Dexcom G6 Transmitter, Ozempic.
Industry payments across LA — which companies pay providers there.
